Дания - датски - SEGES Landbrug & Fødevarer

adama northern europe b.v. - mesotrion - suspensionskoncentrat - 100 g/l mesotrion

Дания - датски - SEGES Landbrug & Fødevarer

adama northern europe b.v. - glyphosat - vandopløseligt koncentrat - 360 g/l glyphosat

Дания - датски - Adama

adama - phenmedipham 320 g/l - herbicider

Европейски съюз - датски - EMA (European Medicines Agency)

sanofi b.v. - sevelamer - renal dialysis; hyperphosphatemia - alle andre terapeutiske produkter - renagel is indicated for the control of hyperphosphataemia in adult patients receiving  haemodialysis or peritoneal dialysis. renagel should be used within the context of a multiple therapeutic approach, which could include calcium supplements, 1,25 - dihydroxy vitamin d3 or one of its analogues to control the development of renal bone disease.

Европейски съюз - датски - EMA (European Medicines Agency)

n.v. organon - corifollitropin alfa - reproductive techniques, assisted; ovulation induction; investigative techniques - køn hormoner og modulatorer af den genitale system, - controlled ovarian stimulation (cos) in combination with a gnrh antagonist for the development of multiple follicles in women participating in an assisted reproductive technology (art) program. elonva is indicated for the treatment of adolescent males (14 to less than 18 years and older) with hypogonadotropic hypogonadism, in combination with human chorionic gonadotropin (hcg).

Дания - датски - Lægemiddelstyrelsen (Danish Medicines Agency)

mylan ab - methylphenidathydrochlorid - depottabletter - 18 mg

Дания - датски - Lægemiddelstyrelsen (Danish Medicines Agency)

mylan ab - methylphenidathydrochlorid - depottabletter - 27 mg

Дания - датски - Lægemiddelstyrelsen (Danish Medicines Agency)

mylan ab - methylphenidathydrochlorid - depottabletter - 36 mg

Дания - датски - Lægemiddelstyrelsen (Danish Medicines Agency)

mylan ab - methylphenidathydrochlorid - depottabletter - 54 mg

Европейски съюз - датски - EMA (European Medicines Agency)

nordic group b.v. - tegafur, gimeracil, oteracil - mave neoplasmer - antineoplastiske midler - teysuno is indicated in adults:- for the treatment of advanced gastric cancer when given in combination with cisplatin (see section 5. - as monotherapy or in combination with oxaliplatin or irinotecan, with or without bevacizumab, for the treatment of patients with metastatic colorectal cancer for whom it is not possible to continue treatment with another fluoropyrimidine due to hand-foot syndrome or cardiovascular toxicity that developed in the adjuvant or metastatic setting.